JS

Jo Shen

Pharmaceutical senior executive | Vivo Capital Venture Partners | co-founder & CEO of ScinoPharm Taiwan

Saratoga, California

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Education

Lists including Jo

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

T(
TCA (Taiwan CDMO Alliance)

2024

  • Head

    2024

SB
Steminent Biotherapeutics

2024

  • Independent Board Member

    2024

Senhua Pharma

2023

  • Board Member

    2023

AM
AnHorn Medicines

2023

  • Board Member

    2023

HP
Handa Pharmaceuticals

2022

  • Board Member

    2022

LT
Lumosa Therapeutics Co., Ltd.

2021

  • Independent Board Member

    2021

OP
OBIGEN PHARMA

2021

  • Board Member

    2021

FP
Formosa Pharmaceuticals, Inc.

2017

  • Board Member

    2017

VC
Vivo Capital

2016

  • Venture Partner

    2016

TB
Taiwan Bio Industry Organization (Taiwan BIO)

2014

  • Vice Chairman

    2014